These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

563 related articles for article (PubMed ID: 33739483)

  • 21. Evaluation of Orthogonal Testing Algorithm for Detection of SARS-CoV-2 IgG Antibodies.
    Xu G; Emanuel AJ; Nadig S; Mehrotra S; Caddell BA; Curry SR; Nolte FS; Babic N
    Clin Chem; 2020 Dec; 66(12):1531-1537. PubMed ID: 32894753
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SARS-CoV-2 S1 and N-based serological assays reveal rapid seroconversion and induction of specific antibody response in COVID-19 patients.
    Algaissi A; Alfaleh MA; Hala S; Abujamel TS; Alamri SS; Almahboub SA; Alluhaybi KA; Hobani HI; Alsulaiman RM; AlHarbi RH; ElAssouli MA; Alhabbab RY; AlSaieedi AA; Abdulaal WH; Al-Somali AA; Alofi FS; Khogeer AA; Alkayyal AA; Mahmoud AB; Almontashiri NAM; Pain A; Hashem AM
    Sci Rep; 2020 Oct; 10(1):16561. PubMed ID: 33024213
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic performance of four SARS-CoV-2 antibody assays in patients with COVID-19 or with bacterial and non-SARS-CoV-2 viral respiratory infections.
    Huber T; Steininger P; Irrgang P; Korn K; Tenbusch M; Diesch K; Achenbach S; Kremer AE; Werblow M; Vetter M; Bogdan C; Held J
    Eur J Clin Microbiol Infect Dis; 2021 Sep; 40(9):1983-1997. PubMed ID: 34109500
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The complexities of SARS-CoV-2 serology.
    Houlihan CF; Beale R
    Lancet Infect Dis; 2020 Dec; 20(12):1350-1351. PubMed ID: 32979317
    [No Abstract]   [Full Text] [Related]  

  • 25. Dynamic Changes of Antibodies to SARS-CoV-2 in COVID-19 Patients at Early Stage of Outbreak.
    Shu H; Wang S; Ruan S; Wang Y; Zhang J; Yuan Y; Liu H; Wu Y; Li R; Pan S; Ouyang Y; Yuan S; Zhou P; Shang Y
    Virol Sin; 2020 Dec; 35(6):744-751. PubMed ID: 32720214
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Highly Sensitive and Specific SARS-CoV-2 Spike- and Nucleoprotein-Based Fluorescent Multiplex Immunoassay (FMIA) to Measure IgG, IgA, and IgM Class Antibodies.
    Solastie A; Virta C; Haveri A; Ekström N; Kantele A; Miettinen S; Lempainen J; Jalkanen P; Kakkola L; Dub T; Julkunen I; Melin M
    Microbiol Spectr; 2021 Dec; 9(3):e0113121. PubMed ID: 34787485
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of a quantitative COVID-19 multiplex assay and its use for serological surveillance in a low SARS-CoV-2 incidence community.
    Guarino C; Larson E; Babasyan S; Rollins A; Joshi LR; Laverack M; Parrilla L; Plocharczyk E; Diel DG; Wagner B
    PLoS One; 2022; 17(1):e0262868. PubMed ID: 35061843
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development and evaluation of a serological test for diagnosis of COVID-19 with selected recombinant spike proteins.
    Zhang P; Gao Q; Wang T; Ke Y; Mo F; Jia R; Liu W; Liu L; Zheng S; Liu Y; Li L; Wang Y; Xu L; Hao K; Min W; Liu X; Yang R; Li S; Lin C; Zhao Y
    Eur J Clin Microbiol Infect Dis; 2021 May; 40(5):921-928. PubMed ID: 33184753
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk Factors for Being Seronegative following SARS-CoV-2 Infection in a Large Cohort of Health Care Workers in Denmark.
    Johannesen CK; Rezahosseini O; Gybel-Brask M; Kristensen JH; Hasselbalch RB; Pries-Heje MM; Nielsen PB; Knudsen AD; Fogh K; Norsk JB; Andersen O; Jensen CAJ; Torp-Pedersen C; Rungby J; Ditlev SB; Hageman I; Møgelvang R; Dessau RB; Sørensen E; Harritshøj LH; Folke F; Sten C; Møller MEE; Engsig FN; Ullum H; Jørgensen CS; Ostrowski SR; Bundgaard H; Iversen KK; Fischer TK; Nielsen SD
    Microbiol Spectr; 2021 Oct; 9(2):e0090421. PubMed ID: 34668738
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Rapid, Multiplex Dual Reporter IgG and IgM SARS-CoV-2 Neutralization Assay for a Multiplexed Bead-Based Flow Analysis System.
    Angeloni S; Cameron A; Pecora ND; Dunbar S
    J Vis Exp; 2021 Apr; (170):. PubMed ID: 33900295
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers.
    Lumley SF; O'Donnell D; Stoesser NE; Matthews PC; Howarth A; Hatch SB; Marsden BD; Cox S; James T; Warren F; Peck LJ; Ritter TG; de Toledo Z; Warren L; Axten D; Cornall RJ; Jones EY; Stuart DI; Screaton G; Ebner D; Hoosdally S; Chand M; Crook DW; O'Donnell AM; Conlon CP; Pouwels KB; Walker AS; Peto TEA; Hopkins S; Walker TM; Jeffery K; Eyre DW;
    N Engl J Med; 2021 Feb; 384(6):533-540. PubMed ID: 33369366
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Longitudinal Monitoring of SARS-CoV-2 IgM and IgG Seropositivity to Detect COVID-19.
    Suhandynata RT; Hoffman MA; Kelner MJ; McLawhon RW; Reed SL; Fitzgerald RL
    J Appl Lab Med; 2020 Sep; 5(5):908-920. PubMed ID: 32428207
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic Potential of a Luminex-Based Coronavirus Disease 2019 Suspension Immunoassay (COVID-19 SIA) for the Detection of Antibodies against SARS-CoV-2.
    Hoffman T; Kolstad L; Lindahl JF; Albinsson B; Bergqvist A; Rönnberg B; Lundkvist Å
    Viruses; 2021 May; 13(6):. PubMed ID: 34073484
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serological assay for anti-SARS-CoV-2 antibodies improves sensitivity of diagnosis of COVID-19 patients.
    Rostamzadeh D; Mortezagholi S; Alinejad M; Jooya SR; Eskandarian M; Metvaei A; Vafaei S; Aboulghasemi H; Younesi V; Shabani M
    Med Microbiol Immunol; 2021 Dec; 210(5-6):283-289. PubMed ID: 34564742
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Highlighted Prospects of an IgM/IgG Antibodies Test in Identifying Individuals With Asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection.
    Li Y; He Q; Yu R; Jiang H; Wang W; Feng D; Hou G; Zhou H; Jiang Y; Xiang Z
    Arch Pathol Lab Med; 2021 Jan; 145(1):39-45. PubMed ID: 32966561
    [TBL] [Abstract][Full Text] [Related]  

  • 36. COVID-19 Serology at Population Scale: SARS-CoV-2-Specific Antibody Responses in Saliva.
    Pisanic N; Randad PR; Kruczynski K; Manabe YC; Thomas DL; Pekosz A; Klein SL; Betenbaugh MJ; Clarke WA; Laeyendecker O; Caturegli PP; Larman HB; Detrick B; Fairley JK; Sherman AC; Rouphael N; Edupuganti S; Granger DA; Granger SW; Collins MH; Heaney CD
    J Clin Microbiol; 2020 Dec; 59(1):. PubMed ID: 33067270
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical applications of detecting IgG, IgM or IgA antibody for the diagnosis of COVID-19: A meta-analysis and systematic review.
    Chen M; Qin R; Jiang M; Yang Z; Wen W; Li J
    Int J Infect Dis; 2021 Mar; 104():415-422. PubMed ID: 33450372
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression and purification of recombinant SARS-CoV-2 nucleocapsid protein in inclusion bodies and its application in serological detection.
    Li G; Li W; Fang X; Song X; Teng S; Ren Z; Hu D; Zhou S; Wu G; Li K
    Protein Expr Purif; 2021 Oct; 186():105908. PubMed ID: 34048905
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of the Clinical Performances of the Abbott Alinity IgG, Abbott Architect IgM, and Roche Elecsys Total SARS-CoV-2 Antibody Assays.
    Harley K; Gunsolus IL
    J Clin Microbiol; 2020 Dec; 59(1):. PubMed ID: 33106364
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exploring beyond clinical routine SARS-CoV-2 serology using MultiCoV-Ab to evaluate endemic coronavirus cross-reactivity.
    Becker M; Strengert M; Junker D; Kaiser PD; Kerrinnes T; Traenkle B; Dinter H; Häring J; Ghozzi S; Zeck A; Weise F; Peter A; Hörber S; Fink S; Ruoff F; Dulovic A; Bakchoul T; Baillot A; Lohse S; Cornberg M; Illig T; Gottlieb J; Smola S; Karch A; Berger K; Rammensee HG; Schenke-Layland K; Nelde A; Märklin M; Heitmann JS; Walz JS; Templin M; Joos TO; Rothbauer U; Krause G; Schneiderhan-Marra N
    Nat Commun; 2021 Feb; 12(1):1152. PubMed ID: 33608538
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.